Latest Commercialization News

Tivan Limited has reported exceptional fluorite assay results from its Sandover Project, with grades reaching up to 91.4% CaF2 and a mineralised strike length now extending to 7 kilometres. The company is advancing towards a maiden drilling campaign scheduled for October 2025.

EMVision Medical Devices has secured a $5 million non-dilutive government grant to accelerate global commercialisation of its innovative First Responder portable brain scanner, aimed at revolutionising pre-hospital stroke and brain injury care.

Bubs Australia has submitted critical clinical trial data to the US FDA, marking a pivotal step toward permanent approval for its infant formulas in the US market.

Lunnon Metals has completed a detailed Scoping Study for its Lady Herial gold deposit, confirming a short-life, high-grade open pit opportunity with strong financial prospects. The study, based largely on Measured and Indicated Resources, sets the stage for commercial negotiations with Gold Fields and potential near-term production.

Octava Minerals reports encouraging early-stage bioleaching results from CSIRO on its Byro REE and lithium project, signaling potential for cost-effective and environmentally friendly metal extraction.

Resouro Strategic Metals’ Tiros Project in Brazil has been selected for a major Brazilian government funding initiative aimed at advancing critical mineral production. This endorsement could accelerate the project’s development and bolster its role in the clean energy transition.

Adisyn Ltd has successfully completed a key R&D program on low-temperature graphene deposition, earning full approval and final payment of a $520,000 grant from the Israel Innovation Authority. This milestone validates its cutting-edge semiconductor technology aimed at revolutionizing AI and high-performance computing.

Tourism Holdings Limited has received a conditional, non-binding takeover proposal from a consortium led by BGH Capital and the Trouchet family, signaling a possible shift in ownership for the global RV rental giant.

Renascor Resources has received provisional development authorisation from South Australia’s Minister for Planning to build a commercial-scale battery anode material plant, marking a pivotal step in its vertically integrated graphite project.

NH3 Clean Energy reports strong Pre-FEED results for its WAH2 clean ammonia project, highlighting robust economics and strategic partnerships while facing key risks around gas supply and funding.

Clarity Pharmaceuticals’ novel PET imaging agent Cu-SAR-Bombesin demonstrated safety and effectiveness in detecting prostate cancer recurrence missed by standard scans in its Phase II SABRE trial. The agent identified lesions in about one-third of patients with negative or equivocal standard imaging.

CLINUVEL Pharmaceuticals announces the full-time return of Managing Director Dr Philippe Wolgen, focusing on advancing critical product development and corporate initiatives, while Acting CEO Lachlan Hay continues until September 2025.